Revenue
23.3 million USD
2017 Q3 · USD
Exact inputs and evidence
- Revenue: 23329000 USD Source
16 filing records in this dataset, filed from 2014-12-23 to 2017-11-03. Reported financial figures are available; chart coverage varies by period.
23.3 million USD
2017 Q3 · USD
-73.73%
2017 Q3 · %
-12.2 million USD
2017 Q3 · USD
51452000 USD
20000000 USD
25448000 shares
34.91% · 6.59 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
86.2 million USD
2016-10-01 – 2017-09-30
-26.9 million USD
2016-10-01 – 2017-09-30
-33.7 million USD
2016-10-01 – 2017-09-30
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2017-11-03.
Financial data available through: 2016-12-31.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
USD 61.57 million
–
Current period
USD 75.18 million
–
75184000 − 61570000 = 13614000 USD
61570000 USD · 2015-01-01 – 2015-12-31
Inspect prior input Prior source75184000 USD · 2016-01-01 – 2016-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 18.3 million
–
Current period
−USD 28.73 million
–
-28730000 − -18300000 = -10430000 USD
-18300000 USD · 2015-01-01 – 2015-12-31
Inspect prior input Prior source-28730000 USD · 2016-01-01 – 2016-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 14.16 million
–
Current period
−USD 20.07 million
–
-20071000 − -14158000 = -5913000 USD
-14158000 USD · 2015-01-01 – 2015-12-31
Inspect prior input Prior source-20071000 USD · 2016-01-01 – 2016-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Capital expenditure.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2013 2013-01-01 – 2013-12-31 | 32545000 | 44893000 Derived | -12348000 | 1048000 Derived | -13396000 | -13798000 Derived | Source
|
| 2014 2014-01-01 – 2014-12-31 | 48820000 | 53921000 Derived | -5101000 | 1828000 Derived | -6929000 | -9776000 Derived | Source
|
| 2015 2015-01-01 – 2015-12-31 | 61570000 | 77426000 Derived | -15856000 | 2444000 Derived | -18300000 | -17560000 Derived | Source
|
| 2016 2016-01-01 – 2016-12-31 | 75184000 | 101899000 Derived | -26715000 | 2015000 Derived | -28730000 | Unavailable | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2013 | Revenue | 32545000 |
|
| 2014 | Revenue | 48820000 |
|
| 2015 | Revenue | 61570000 |
|
| 2016 | Revenue | 75184000 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2013 | Year over year | No prior comparable period |
|
| 2014 | Year over year | 50% |
|
| 2015 | Year over year | 26.1% |
|
| 2016 | Year over year | 22.1% |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2013 | Operating margin | -37.9% |
|
| 2014 | Operating margin | -10.4% |
|
| 2015 | Operating margin | -25.8% |
|
| 2016 | Operating margin | -35.5% |
|
| 2013 | Net margin | -41.2% |
|
| 2014 | Net margin | -14.2% |
|
| 2015 | Net margin | -29.7% |
|
| 2016 | Net margin | -38.2% |
|
| 2013 | Free cash flow margin | -42.4% |
|
| 2014 | Free cash flow margin | -20% |
|
| 2015 | Free cash flow margin | -28.5% |
|
| 2016 | Free cash flow margin | Not reported |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2013 | Operating cash flow | -13211000 |
|
| 2014 | Operating cash flow | -8777000 |
|
| 2015 | Operating cash flow | -14158000 |
|
| 2016 | Operating cash flow | -20071000 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2013 | Free cash flow | -13798000 |
|
| 2014 | Free cash flow | -9776000 |
|
| 2015 | Free cash flow | -17560000 |
|
| 2016 | Free cash flow | Unavailable |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2013-12-31 | Liabilities / assets | Not reported | No source recorded |
| 2014 | Liabilities / assets | 145.7% |
|
| 2015 | Liabilities / assets | 33.9% |
|
| 2016 | Liabilities / assets | 50.8% |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2013-12-31 | Current assets / current liabilities | Not reported | No source recorded |
| 2014 | Current assets / current liabilities | 2× |
|
| 2015 | Current assets / current liabilities | 9.02× |
|
| 2016 | Current assets / current liabilities | 2.2× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2013 2013-01-01 – 2013-12-31 | −USD 13.4 million Exact valueExact value: -13396000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 13.21 million Exact valueExact value: -13211000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 587,000 Exact valueExact value: 587000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 13.8 million Calculation and evidence-13211000 − 587000 USD Exact free cash flow: -13798000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2014 2014-01-01 – 2014-12-31 | −USD 6.93 million Exact valueExact value: -6929000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 8.78 million Exact valueExact value: -8777000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 999,000 Exact valueExact value: 999000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 9.78 million Calculation and evidence-8777000 − 999000 USD Exact free cash flow: -9776000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2015 2015-01-01 – 2015-12-31 | −USD 18.3 million Exact valueExact value: -18300000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 14.16 million Exact valueExact value: -14158000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 3.4 million Exact valueExact value: 3402000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 17.56 million Calculation and evidence-14158000 − 3402000 USD Exact free cash flow: -17560000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2016 2016-01-01 – 2016-12-31 | −USD 28.73 million Exact valueExact value: -28730000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 20.07 million Exact valueExact value: -20071000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
16 filings · 1,104 latest values · 1,104 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001374128, 1374128, ENTL, edgar:1374128
Also known as ENTELLUS MEDICAL INC